Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age

AIM: The purpose of this study was to evaluate the outcomes of infants diagnosed with retinoblastoma before 6 months of age, including the need for chemoreduction (CRD). In this age group, dosage of CRD was reduced due to its potential for toxicity. METHODS: This is a retrospective review from 2000...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ocul Oncol Pathol
Autors principals: Berry, Jesse L., Jubran, Rima, Lee, Thomas C., Murphree, A. Linn, Lee, Diana, Kim, Jonathan W.
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2015
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4847682/
https://ncbi.nlm.nih.gov/pubmed/27172253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000370215
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars